Spyridon Servos Email and Phone Number
Spyridon Servos work email
- Valid
- Valid
- Valid
Spyridon Servos personal email
- Valid
- Valid
Spiros Servos PhD, MBARNA Therapeutics Expert & Dealmaker with a proven track record of securing over $110M in upfront payments through 30+ partnerships, totalling over $7B in value. Leveraging 20+ years of experience in gene therapy, I specialize in commercializing cutting-edge RNA therapeutics to improve patient access and affordability, particularly in neurodegenerative diseases. With a Ph.D. in molecular biology and an MBA from Imperial College, I possess a deep understanding of both scientific principles and business strategy. My key competencies include partnering, asset disposition, due diligence, technology scouting, alliance management, business intelligence, valuations, and revenue forecasting. I have a proven ability to identify and evaluate emerging technologies, build strong relationships with key stakeholders, and drive innovation in the RNA therapeutics space. By combining my scientific expertise with my business acumen, I have consistently delivered exceptional results for my clients and contributed to the growth of the RNA therapeutics industry.Key Competencies:Partnering, Scouting for New Technologies, Disposition of Assets, Due Diligence (IntraLinks), Data mining with my own Business Intelligence tool (Python), Valuations (Xplico), Commercialisation evaluation algorithms incorporating HTA pricing methodology.Book an appointment now: https://bit.ly/3V747Nk
Sergene Biosciences Ltd
View- Website:
- sergenebio.co.uk
- Employees:
- 2
-
Managing DirectorSergene Biosciences Ltd Oct 2024 - PresentSerGene Biosciences Ltd is a strategic advisory firm specializing in cell and gene therapy for biopharmaceutical companies. With a deep understanding of viral and non-viral delivery platforms, we provide expert guidance on business development, licensing, mergers & acquisitions, and product development.Our expertise includes:• Gene Therapy Strategy: Developing tailored gene therapy strategies aligned with therapeutic goals and regulatory requirements.• Licensing Deals: Negotiating optimal licensing agreements that protect intellectual property and maximize revenue potential.• M&A Due Diligence: Conducting comprehensive due diligence assessments to identify risks and opportunities in mergers and acquisitions.• Product Development: Optimizing nonclinical and clinical study designs to ensure efficient and effective product development.• Financial Modelling: Providing robust financial projections and risk assessments to support informed decision-making. (Xplico)• Global Network: Leveraging the advanced features of PartneringONE® to efficiently connect companies with potential partners based on specific business needs and objectives.• Business Strategy: Guide start-ups to define the best business model for commercialising their discoveries.Partner with SerGene Biosciences to leverage our expertise in gene therapy and accelerate your innovation.
-
Freelance Industry ConsultantFreelance May 2024 - Oct 2024Consulting Clients:Lentitek based in Edinburgh, Scotland. Lentitek has developed a unique manufacturing technology that can significantly improve the production quality of the lentivirus vector used in advanced therapies. Get in touch if you want to learn more about evaluating and licensing their technology.SiSaf based in Guildford, England. SiSaf is a biopharmaceutical company developing RNA therapeutics that are principally focused on rare genetic disorders. Get in touch if you want to evaluate and licensing their delivery platform technology or In-House Programs. (Osteopetrosis (ADO2), Achondroplasia, Pancreatic Cancer).
-
Head Of Business DevelopmentSisaf Ltd Dec 2019 - Apr 2024Guildford, England, Gb -
Director Business Development & Market AccessOxford Biomedica Jan 2018 - Aug 2019Oxford, Oxfordshire, Gb -
Director Of Business DevelopmentOxford Biomedica Feb 2015 - Dec 2018Oxford, Oxfordshire, GbTo represent the Company commercially and secure partnerships, collaborations that maximize potential revenues as well as identify and secure new opportunities to in-licence or acquire.
-
Business Development ConsultantOxford Biomedica Sep 2014 - Jan 2015Oxford, Oxfordshire, Gb
-
Manager Of Business Development, Partnering And AssetsEmergent Biosolutions Apr 2012 - Dec 2013Gaithersburg, Maryland, UsReporting to the VP of Business Development, previously to Senior Director. Responsible for coordinating all asset partnering activities of Emergent BioSciences Division and reporting to Senior and Executive Management. Achievements- Identified partner and co-managed successful sale of spiVEC™ platform- Agreed terms for commercial license with partner on a Biodefense indication- Initiated four partnering opportunities for the MVAtor™ platform (on-going) - Training in drafting commercial contracts for the pharmaceutical industry at Falconbury -
Senior Business AnalystEmergent Biosolutions Oct 2006 - May 2012Gaithersburg, Maryland, UsReported to the Senior Director of Business Development. Responsible for the Business Analysis function in Emergent Biosolutions BD group.Achievements- Acquisition of Zanolimumab (Financial analysis, Due diligence)- Spin-out of OETC (Financial modelling of Joint-Venture, Due Diligence, set up)- Managed UK and European BD partnering activities for the last two years of this role- Identified 5 in-licensing, 2 out-licensing and 2 M&A opportunities- Represented the company at partnering events, every year since 2006- Created an automated rNPV valuation model template for the BD group
-
Business Intelligence ManagerOxford Gene Technology Jan 2005 - Sep 2006Kidlington, Oxfordshire, GbReporting to the Commercial Director. Accountable for the Business Intelligence function across the OGT Group. Achievements- Identified more than 50 companies that infringed OGT’s intellectual property. - Coordinated the development of grant proposals that secured €900,000 - Established a Knowledge Management System, which combined comprehensive market research and business intelligence. -
Decision Support ManagerOxford Gene Technology 2003 - Dec 2004Kidlington, Oxfordshire, GbReported to the Group Managing Director. Responsible for the Budget, purchasing and CAPEX. Achievements- Co-led and delivered the operating plan for five business units. - Supported several licensing deals including a $62.5M settlement deal with Affymetrix in 2004.- Prepared Budgets (£6m) and Forecasts for five BUs of the OGT group- Supervised two BU Heads on P&L accountability.- Developed a Budgeting tool that could be updated by the BU heads and consolidate all company accounts automatically
-
Secondment To Business DevelopmentArk Therapeutics 2002 - 2003Reported to the Commercial Director. MBA project: Evaluation of the commercialization potential and strategy targeting solid tumours markets.Achievements- Prepared sales forecasts for Scavidin, Solima and oxLDL diagnostic kit- Developed a novel commercialization algorithm for solid tumours markets- Evaluated pharmaceutical projects using real options- Organised out-licensing documentation for VEGF antagonists
-
Phd StudentWellcome Biotech 1989 - 1992Construction of Oral Vaccines, S.typhi, M.tuberculosis.
Spyridon Servos Skills
Spyridon Servos Education Details
-
Imperial College LondonHealth Management -
University Of PatrasOral Vaccines
Frequently Asked Questions about Spyridon Servos
What company does Spyridon Servos work for?
Spyridon Servos works for Sergene Biosciences Ltd
What is Spyridon Servos's role at the current company?
Spyridon Servos's current role is Managing Director | Business Development & Licensing | Partnering | Collaborations | Risk-adjusted net present value (rNPV) Analysis for Deal Term Negotiations, Strategic & Investment Decisions.
What is Spyridon Servos's email address?
Spyridon Servos's email address is s_****@****hoo.com
What schools did Spyridon Servos attend?
Spyridon Servos attended Imperial College London, University Of Patras.
What are some of Spyridon Servos's interests?
Spyridon Servos has interest in Mergers And Acquisitions, Interactive Valuation Modelling, Corporate Financial Reporting.
What skills is Spyridon Servos known for?
Spyridon Servos has skills like Biotechnology, Pharmaceutical Industry, Commercialization, Strategy, Lifesciences, Biopharmaceuticals, Drug Discovery, Life Sciences, Technology Transfer, Molecular Biology, R&d, Oncology.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial